MGI Tech Co. Ltd. (MGI), a world-leading life science innovator, is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology DNBSEQ TM, MGI focuses on Research & Development, production and sales of sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI owns more than 140 valid PCT patents and 870 valid patent applications. Operating in over 70 countries MGI has established local technical support teams in Australia, Europe, Americas, and South-east Asia. With the mission is to develop and promote advanced life science tools for future healthcare, MGI has more than 1,800 employees worldwide and strives to lead life science innovation.
Versatility to satisfy multiple sequencing needs.
DNBSEQ-G50 adopts a whole new biochemical system design to support rapid sequencing in various different reads modes.
The MGISP-100 provides automation for sample preparation and library preparation. The system has an 8 channel pipetting head, suitable for preparing 8 or 16 samples in one run.
The MGISP-960 provides automation for sample preparation and library preparation. The system has a 96 channel pipetting head, suitable for preparing 8 to 966 samples in one run.
Latest generation of world leading sequencing technology from MGI.